ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Pitolisant in Patients With Prader-Willi Syndrome

ClinicalTrials.gov ID: NCT06366464

Public ClinicalTrials.gov record NCT06366464. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients With Prader-Willi Syndrome

Study identification

NCT ID
NCT06366464
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Harmony Biosciences Management, Inc.
Industry
Enrollment
134 participants

Conditions and interventions

Interventions

  • Pitolisant tablet Drug
  • Placebo tablet Other

Drug · Other

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2024
Primary completion
Jun 30, 2026
Completion
Jun 30, 2027
Last update posted
Mar 16, 2026

2024 – 2027

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Santa Monica Clinical Trials Los Angeles California 90025 Recruiting
Center of Excellence in Diabetes and Endocrinology Sacramento California 95821-2123 Recruiting
Rady Children's Hospital - Scan Diego San Diego California 92123 Recruiting
Colorado Children's Hospital Aurora Colorado 80045 Recruiting
Nemours Children's Hospital Wilmington Delaware 19803-3607 Recruiting
Atlanta Diabetes Associates Atlanta Georgia 30318 Withdrawn
Emory University School of Medicine Atlanta Georgia 30322 Recruiting
Rare Disease Research Atlanta Georgia 30329 Withdrawn
Ann And Robert H Lurie Children's Hospital of Chicago Chicago Illinois 60611 Recruiting
Riley Children's Hospital Indianapolis Indiana 46202 Recruiting
Johns Hopkins Hospital Baltimore Maryland 21224 Recruiting
Mayo Clinic-PPDS Rochester Minnesota 55905 Recruiting
Maimonides Medical Center Brooklyn New York 11219 Recruiting
Montefiore Medical Center The Bronx New York 10467 Recruiting
Science 37 (at-home option) Morrisville North Carolina 27560 Recruiting
CTI Clinical Research Center Cincinnati Ohio 45212 Withdrawn
Center for Human Genetics Cleveland Ohio 441016 Recruiting
Texas Children's Hospital Houston Texas 77030 Recruiting
Road Runner Research San Antonio Texas 78249-3539 Recruiting
Texas Valley Clinical Research Weslaco Texas 78596 Terminated
Childrens Hospital of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06366464, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06366464 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →